Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Dental Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Xu, Q.A.
Right arrow Articles by Guo, J.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, Q.A.
Right arrow Articles by Guo, J.H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Immunogenicity and Persistence of a Targeted Anti-caries DNA Vaccine

Q.A. Xu1,{dagger}, F. Yu2,{dagger}, M.W. Fan1,*, Z. Bian1, Z. Chen1, B. Fan1, R. Jia1 and J.H. Guo1

1 The Key Laboratory for Oral Biomedical Engineering of Ministry of Education, School & Hospital of Stomatology, Wuhan University, Luoyu Road 237, 430079 Wuhan, Hubei, China; and
2 now at Center of Stomatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;


Figure 1
View larger version (33K):
[in this window]
[in a new window]

  		Figure 1. Antibody responses generated following intranasal delivery of bupivacaine:DNA complexes. BALB/c mice were immunized with 100 µg pGJA-P/VAX or pVAX1 mixed with bupivacaine on days 0 and 14. Serum and saliva samples were collected biweekly for ELISA. Values are expressed as the means plus standard deviations of the log10 antibody titer (5 animals per group). *Significantly different from control group (p < 0.01). {uparrow} days of immunization. (A) Serum IgG anti-PAc antibody levels. (B) Serum IgG anti-GTF-I antibody levels. (C) Salivary IgA anti-PAc antibody levels. (D) Salivary IgA anti-GTF-I antibody levels.

 

Figure 2
View larger version (11K):
[in this window]
[in a new window]

  		Figure 2. PCR analysis of mouse nasal-associated lymphoid tissue and the draining cervical lymph node DNA samples extracted 6 mos after intranasal delivery of bupivacaine:DNA complexes. Lane 1, DNA marker DL2000; Lane 2, the nasal-associated lymphoid tissue DNA samples from pGJA-P/VAX-immunized mice; Lane 3, the nasal-associated lymphoid tissue DNA samples from normal mice spiked with pGJA-P/VAX; Lane 4, the nasal-associated lymphoid tissue DNA samples from pVAX1 vector-immunized mice; Lane 5, the draining cervical lymph node DNA samples from pGJA-P/VAX-immunized mice; Lane 6, the draining cervical lymph node DNA samples from normal mice spiked with pGJA-P/VAX; and Lane 7, the draining cervical lymph node DNA samples from pVAX1 vector-immunized mice.

 

Journal of Dental Research, Vol. 85, No. 10, 915-918 (2006)
DOI: 10.1177/154405910608501008
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?